Did You Know?

Editor’s Picks

Latest News

AXT107 Restores Healthy, Non-Leaky Vasculature in the Eye by Inhibiting VEGFR2 and Activating Tie2, the Two Clinically Validated Pathways in Diseases of the Retina

AXT107 exhibited a dual mechanism of action as a monotherapy, disrupting a key component of the Vascular Endothelial Growth Factor...

Interim Analysis Showed Treatment with OPSUMIT® (macitentan) Associated with Significant Improvement in Right Ventricular (RV) Function and Pulmonary Vascular Resistance (PVR) in Patients with Pulmonary Arterial Hypertension (PAH)

Shimadzu Corporation Releases Nexera Ultra High-Performance Liquid Chromatograph Series, Incorporating Artificial intelligence as Analytical Intelligence, to Detect and Resolve Issues Automatically

error: Content is protected !!